Abstract
Primary central nervous system (CNS) lymphoma is a rare CNS neoplasm. Its highest incidence is in the elderly and the immunocompromised. The initial steps in establishing a diagnosis involve CNS imaging. Familiarity with the clinical presentation is important in order to limit the risk of a nondiagnostic biopsy. In addition to confirming the diagnosis, it is wise to evaluate for extra-CNS disease. There are important differences in the presentation and evaluation of immunocompetent patients and those of immunocompromised patients; we will delineate these in this review. Appropriate initial clinical evaluations facilitate optimal therapeutic management for patients with primary CNS lymphoma. This is of particular importance because primary CNS lymphoma is a potentially curable disease, despite the high likelihood of recurrence.
Original language | English (US) |
---|---|
Pages (from-to) | 17-27 |
Number of pages | 11 |
Journal | ONCOLOGY (United States) |
Volume | 32 |
Issue number | 1 |
State | Published - Jan 1 2018 |
ASJC Scopus subject areas
- Oncology
- Cancer Research